Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood.
about
Neural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challengesMolecular diagnostics of neurodegenerative disordersHuntington’s disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer’s diseaseMetabolic profiling for the identification of Huntington biomarkers by on-line solid-phase extraction capillary electrophoresis mass spectrometry combined with advanced data analysis tools.Age-associated chromatin relaxation is enhanced in Huntington's disease mice.miR-196a Ameliorates Cytotoxicity and Cellular Phenotype in Transgenic Huntington's Disease Monkey Neural CellsStudy of plasma-derived miRNAs mimic differences in Huntington's disease brain.Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington's disease peripheral blood samplesCommon disease signatures from gene expression analysis in Huntington's disease human blood and brainRNA-Seq of Huntington's disease patient myeloid cells reveals innate transcriptional dysregulation associated with proinflammatory pathway activation.Identifying a gene expression signature of cluster headache in bloodThe microRNA regulatory network: a far-reaching approach to the regulate the Wnt signaling pathway in number of diseases.Modern Genome Editing Technologies in Huntington's Disease Research.Huntington's Disease: Calcium Dyshomeostasis and Pathology ModelsA Putative Blood-Based Biomarker for Autism Spectrum Disorder-Associated Ileocolitis.Adhesion Regulating Molecule 1 Mediates HAP40 Overexpression-Induced Mitochondrial Defects.Transcriptome profile of yeast reveals the essential role of PMA2 and uncharacterized gene YBR056W-A (MNC1) in adaptation to toxic manganese concentration.Age-associated bimodal transcriptional drift reduces intergenic disparities in transcription.Therapy development in Huntington disease: From current strategies to emerging opportunities.Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model.Peripheral blood gene expression reveals an inflammatory transcriptomic signature in Friedreich's ataxia patients
P2860
Q26775932-397E4600-BCE6-42DF-AABB-10305F8613C6Q26786821-F8900267-797C-4414-BD3A-2F5E38DF5CD7Q29248581-B6F57EA6-8965-4BDF-9BD8-26A25BF16FA8Q31032933-5B44A9ED-4297-4869-896F-09250BB53502Q33563614-24A14A92-FBF1-48E7-A95D-0DFB57E005B9Q36133682-A2E28ACF-2810-47A0-BA21-66DE9CD2C368Q36469923-192C1F5B-35BD-457A-A677-B597B224D1ABQ37131903-1B33A943-B925-41A2-B79E-632057D50361Q37141460-FC14120C-336C-42AA-8666-711F7D8EB257Q37530090-70EB4AE9-2CC5-425E-9228-95AD9D121718Q37579127-33A2597C-9CE8-43CD-A332-EAF428089C51Q38622178-E8363C94-9601-41C5-A623-3EF60721BB75Q39106522-1150328F-71C2-4E7F-8F60-B2A6E43E5D18Q39456024-B896487F-F4C3-424B-82E5-49FBBD17BB69Q41523753-EB74BCD3-BD74-4E8C-BF6E-38711D9E45F6Q45305874-8B8EF71C-F1BF-44E9-BC4D-53303197E80FQ48304868-8D6A7456-54BD-49CF-84D2-7B71BBE6F6F2Q53070588-BB8FF722-ADA8-43F3-9015-7D07CD90E0DEQ53716390-482FFC2B-E545-449C-977D-293E2844C83CQ55497345-1DA07F6A-FBC6-457C-A1A4-C206841909FCQ57164109-0EBF0200-4DDA-44CF-AD1B-E880ED4E3714
P2860
Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Huntington's disease biomarker ...... equencing in peripheral blood.
@ast
Huntington's disease biomarker ...... equencing in peripheral blood.
@en
type
label
Huntington's disease biomarker ...... equencing in peripheral blood.
@ast
Huntington's disease biomarker ...... equencing in peripheral blood.
@en
altLabel
Huntington’s disease biomarker ...... sequencing in peripheral blood
@en
prefLabel
Huntington's disease biomarker ...... equencing in peripheral blood.
@ast
Huntington's disease biomarker ...... equencing in peripheral blood.
@en
P2093
P2860
P50
P921
P356
P1476
Huntington's disease biomarker ...... equencing in peripheral blood.
@en
P2093
Erik van Duijn
GertJan B van Ommen
Johan T den Dunnen
Roos C van der Mast
Willeke M C van Roon-Mom
Yavuz Ariyurek
P2860
P2888
P304
P356
10.1038/EJHG.2014.281
P577
2015-01-28T00:00:00Z